C-Terminal modification of polytheonamide B uncouples its dual functions in MCF-7 cancer cells
Yun-Wei Xue1, Kensuke Miura1, Hiroaki Itoh1
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. inoue@mol.f.u-tokyo.ac.jp.
Abstract:
Polytheonamide B (1) is an exceptionally large peptide that forms a transmembrane ion channel. The potent cytotoxicity of 1 against MCF-7 cancer cells originates from its two ion transport functions. Compound 1 depolarizes the plasma membrane and neutralizes acidic lysosomes. Here, we describe how we uncoupled these functions by designing and synthesizing new analogues of 1.
Insights
Polytheonamide B, a large peptide, exhibits cytotoxicity against cancer cells by disrupting cell membranes and neutralizing lysosomes. Researchers created new analogues to separate these two distinct ion transport functions.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Polytheonamide B is a large peptide with potent cytotoxicity against MCF-7 cancer cells.
- Its cytotoxicity stems from two distinct ion transport functions: plasma membrane depolarization and lysosome neutralization.
Purpose of the Study:
- To understand the specific contributions of each ion transport function to Polytheonamide B's cytotoxicity.
- To design and synthesize novel analogues of Polytheonamide B with uncoupled functions.
Main Methods:
- Synthesis of Polytheonamide B analogues.
- Characterization of ion transport activities (membrane depolarization, lysosome neutralization).
- Assessment of cytotoxicity against MCF-7 cancer cells.
Main Results:
- Successful design and synthesis of Polytheonamide B analogues.
- Demonstration of uncoupling the membrane depolarization and lysosome neutralization functions.
- Identification of analogues with selective activity.
Conclusions:
- The two ion transport functions of Polytheonamide B can be pharmacologically separated.
- This uncoupling provides insights into the mechanism of action and potential for targeted cancer therapy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....


